Composition comprising methanesulfonate salt of ethyl 3-[(2- {[4 (hexyloxycarbonylamino-imino-methyl) phenylamino]- methy}-1-methyl-1H benzimidazole-5-carbonyl)-pyridin-2-ylamino]-propionate
PK140973AUndetermined Publication Date: 2010-10-19BOEHRINGER INGELHEIM PHARMA GMBH & CO KG
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200300189
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-10-19
Abstract
The invention relates to a new administration form for the oral application of the active substance is the methanesulfonate salt of ethyl 3-[(2-{[4 (hexyloxycarbonylamino-imino-methyl) phenylamino] -methyl} -1-methyl-1H benzim idazole-5 -carbonyl)-pryridin-2-yl ¬amino]-propionate.
Need to check novelty before this filing date? Find Prior Art